F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom

F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom

FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next?

FDA panel considers loosening regulations on certain unapproved peptides

Inside the unconventional FDA panel that could reshape the peptide industry

FDA panel rejects only 1 peptide despite backlash

RFK Jr.’s peptide push narrowly gains backing from FDA advisers despite objections from scientists

FDA advisory panel narrowly rejects compounding of one peptide, back another

FDA panel overrules its own scientists to ease access to unproven peptide injections

La nueva batalla de los péptidos: la FDA revisa las sustancias promocionadas en redes sociales mientras sus científicos cuestionan su eficacia

US panel backs trendy peptides despite safety concerns